Health And Medicine
-
Graphene material strengthens nerve signaling in the brain
Less than 20 years after it was developed, a thin, resilient sheet of carbon atoms with remarkable properties known as graphene is transforming biomedical fields as far flung as tissue engineering, neuroprosthetics and drug discovery. Read MoreMar 1, 2018
-
Structure of a stem cell niche
Understanding the specialized environment where stem cells reside is important for developing stem-cell based regenerative therapies. Read MoreFeb 28, 2018
-
Cannabis compound reduces seizures
Cannabidiol (CBD) oils reduced seizures in patients with difficult-to-treat epilepsy, Vanderbilt investigators have found. Read MoreFeb 26, 2018
-
Hope for an RSV vaccine
Newly discovered features in an RSV protein may be useful for rational structure-based vaccine design. Read MoreFeb 23, 2018
-
Mitochondrial mutations and disease
New findings suggest that oxidative stress damages mitochondrial DNA, and they link this damage to a disease state. Read MoreFeb 22, 2018
-
Glaucoma study finds brain fights to preserve vision
A team of researchers, led by David Calkins, PhD, vice chair and director of Research at the Vanderbilt Eye Institute, has made a breakthrough discovery in the field of glaucoma showing new hopes for treatments to preserve vision. Read MoreFeb 22, 2018
-
Linda Sealy receives 2018 AAAS Mentor Award for Lifetime Achievement
Professor Linda Sealy has won the AAAS Mentor Award for Lifetime Achievement for her continued efforts to increase the number of underrepresented minorities in STEM Ph.D. programs. Read MoreFeb 15, 2018
-
A new target for neuroblastoma
Vanderbilt investigators have discovered that a sirtuin protein has oncogenic properties in neuroblastoma cells — and that blocking it reduces their growth and tumor-like characteristics. Read MoreFeb 14, 2018
-
Cognition in rare hormonal disorder
Vanderbilt investigators have conducted the first systematic evaluation of cognitive function in children with a rare genetic disorder. Read MoreFeb 13, 2018
-
Opioid use increases risk of serious infections
Opioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don’t use opioids. Read MoreFeb 12, 2018
-
Protecting transplanted lungs
Acetaminophen may offer a simple treatment to prevent tissue injury following lung transplant, Vanderbilt researchers have discovered. Read MoreFeb 12, 2018
-
Muscular dystrophy clue
Vanderbilt investigators have discovered a role for immune system T cells in slowing the decline in skeletal muscle function in patients with Duchenne muscular dystrophy. Read MoreFeb 9, 2018
-
Study seeks to boost breast tumor immune response
Immunotherapy, which harnesses the power of the immune system, is one of the most promising forms of cancer therapy and has been shown to work well against some types of cancer. Read MoreFeb 8, 2018
-
Study helps map signaling system in brain linked to ASD
Researchers at Vanderbilt University have worked out part of the “wiring diagram” of a signaling system in the brain that has been linked to autism spectrum disorder (ASD). Read MoreFeb 8, 2018
-
AIDS-defining events increase mortality risk: study
When they occur among people living with HIV, certain cancers and opportunistic infections are considered by health authorities as AIDS-defining events, or ADEs. Read MoreFeb 8, 2018
-
Study explores best pre-transplant weight loss options
Vanderbilt researchers are comparing two types of weight-loss options to determine which is the most effective in helping obese patients reach a more ideal weight before undergoing kidney transplant surgery. Read MoreFeb 8, 2018
-
Flu Fighter: Dr. James Crowe is leading a global effort to take the guesswork out of the flu shot
From Vanderbilt Magazine: James Crowe, director of the Vanderbilt Vaccine Center, hopes to create a universal flu vaccine--permanently eliminating the problem of ineffective or under-effective annual flu shots. Read MoreFeb 6, 2018
-
Study evaluates community-based health efforts
A new study from researchers at Vanderbilt and Harvard universities, published this week in the journal Health Affairs, uses federal health survey data to evaluate community-based efforts to address smoking, obesity and other health conditions such as type 2 diabetes and hypertension. Read MoreFeb 1, 2018
-
AAAS, chemistry society honor Lindsley’s research contributions
Craig Lindsley, PhD, co-director of the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD), has been named a fellow of the Royal Society of Chemistry and elected chair-elect of the Section of Pharmaceutical Sciences of the American Association for the Advancement of Science (AAAS). Read MoreFeb 1, 2018
-
Study tracks therapy to slow idiopathic pulmonary fibrosis
Investigators in the Division of Allergy, Pulmonary and Critical Care have launched a pilot study to see if patients with idiopathic pulmonary fibrosis (IPF) can tolerate the addition of a commonly used antiviral drug to standard IPF treatments. The research team believes the drug may ultimately help slow progression of the chronic and progressive disease or reverse its course. Read MoreFeb 1, 2018